289 related articles for article (PubMed ID: 29025958)
1. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
[TBL] [Abstract][Full Text] [Related]
2. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
Vetter NS; Kolb EA; Mills CC; Sampson VB
Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
[TBL] [Abstract][Full Text] [Related]
3. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
Zhu L; Chen Y; Nie K; Xiao Y; Yu H
Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
[TBL] [Abstract][Full Text] [Related]
4. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Robinson AD; Cieślik M; Chandrashekar DS; Agarwal S; Siddiqui J; Daignault S; Carskadon SL; Jing X; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Oncogene; 2016 Dec; 35(49):6330-6340. PubMed ID: 27270442
[TBL] [Abstract][Full Text] [Related]
6. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
7. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
8. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
Zhu M; Zheng Z; Huang J; Ma X; Huang C; Wu R; Li X; Liang Z; Deng F; Wu J; Geng S; Xie C; Zhong C
J Cell Biochem; 2019 Sep; 120(9):15616-15624. PubMed ID: 31042325
[TBL] [Abstract][Full Text] [Related]
9. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance.
Cai X; Duan X; Tang T; Cui S; Wu T
BMC Cancer; 2023 May; 23(1):423. PubMed ID: 37165308
[TBL] [Abstract][Full Text] [Related]
10. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
[TBL] [Abstract][Full Text] [Related]
11. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
[TBL] [Abstract][Full Text] [Related]
12. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
13. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
[No Abstract] [Full Text] [Related]
14. MicroRNA485-3p negatively regulates the transcriptional co-repressor
Du K; Zhang X; Lou Z; Guo P; Zhang F; Wang B; Chen L; Zhang C
Int J Biol Sci; 2018; 14(11):1445-1456. PubMed ID: 30262996
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
16. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma.
Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B
Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
[TBL] [Abstract][Full Text] [Related]
18. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
19. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
